Company CVAbout Advanced Enzyme Technologies Ltd 
Advanced Enzyme Technologies Ltd
Small Cap
Pharmaceuticals & Biotechnology
Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing and sale of enzymes. Advanced Enzyme Technologies Limited was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra. The Company thereafter, got converted into a Public Company and the name of the Company changed to Advanced Biochemicals Limited on May 28, 1992.
Company Coordinates
Company Details
Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi Thane Maharashtra : 400604
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 22.36 Cr
Number of Shares
11.18 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Feb-2023
11.18
22.36
2000
2
Issued under ESOP Scheme
30-Sep-2022
11.18
22.36
4250
0
Issued under ESOP Scheme
30-Sep-2022
11.18
22.36
4250
2
Issued under ESOP Scheme
21-Jul-2022
11.18
22.36
11250
0
Issued under ESOP Scheme
21-Jul-2022
11.18
22.36
11250
2
Issued under ESOP Scheme
20-May-2022
11.18
22.36
5900
0
Issued under ESOP Scheme
20-May-2022
11.18
22.36
5900
2
Issued under ESOP Scheme
05-Feb-2022
11.18
22.36
9200
0
Issued under ESOP Scheme
05-Feb-2022
11.18
22.36
9200
2
Issued under ESOP Scheme
02-Nov-2021
11.18
22.36
13175
2
Issued under ESAR
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 9 Schemes (3.24%)
FIIs
Held by 71 FIIs (25.41%)
Promoter with highest holding
Vasant Rathi (33.18%)
Highest Public shareholder
Orbimed Asia Iii Mauritius Fvci Limited (12.07%)
Individual Investors Holdings
16.95%
Board of Directors
Management
Designation
Remuneration
MUKUND MADHUSUDAN KABRA
Whole-time director
2.43 cr
KEDAR JAGDISH DESAI
Independent Director
14.7 lacs
VASANT RATHI
Chairman (Non-Executive)
9.9 lacs
Pramod Kasat
Independent Director
12.6 lacs
Sanjay Basantani
Company Sec. & Compli. Officer
0
Rajesh Kumar Sharma
Independent Director
3.4 lacs
Rasika Rathi
Non-Exec & Non-Independent Dir
5.8 lacs
Vindokumar Hiralal Jajoo
Independent Director
9.4 lacs
Sunny Sharma
Non-Exec & Non-Independent Dir
3.3 lacs
Rajshree Patel
Independent Director
7.3 lacs
NITIN JAGANNATH DESHMUKH
Independent Director
3.8 lacs
Vandana Tilak.
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Enzymes
222.09
100.00%
Enzymes
Stock DNARevenue and Profits:
Net Sales:
185 Cr
(Quarterly Results - Sep 2025)
Net Profit:
43 Cr
Pharmaceuticals & Biotechnology
INR 3,474 Cr (Small Cap)
23.00
40
1.65%
-0.38
9.93%
2.37
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
